188 related articles for article (PubMed ID: 38507972)
1. Hybrid molecules synergistically mitigate ferroptosis and amyloid-associated toxicities in Alzheimer's disease.
Padhi D; Baruah P; Ramesh M; Moorthy H; Govindaraju T
Redox Biol; 2024 May; 71():103119. PubMed ID: 38507972
[TBL] [Abstract][Full Text] [Related]
2. Polycatechols inhibit ferroptosis and modulate tau liquid-liquid phase separation to mitigate Alzheimer's disease.
Moorthy H; Ramesh M; Padhi D; Baruah P; Govindaraju T
Mater Horiz; 2024 Jul; 11(13):3082-3089. PubMed ID: 38647314
[TBL] [Abstract][Full Text] [Related]
3. A natural polyphenol activates and enhances GPX4 to mitigate amyloid-β induced ferroptosis in Alzheimer's disease.
Baruah P; Moorthy H; Ramesh M; Padhi D; Govindaraju T
Chem Sci; 2023 Sep; 14(35):9427-9438. PubMed ID: 37712018
[TBL] [Abstract][Full Text] [Related]
4. Penthorum chinense Pursh inhibits ferroptosis in cellular and Caenorhabditis elegans models of Alzheimer's disease.
Yong YY; Yan L; Wang BD; Fan DS; Guo MS; Yu L; Wu JM; Qin DL; Law BY; Wong VK; Yu CL; Zhou XG; Wu AG
Phytomedicine; 2024 May; 127():155463. PubMed ID: 38452694
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydroxy stilbene glycoside ameliorates Alzheimer's disease in APP/PS1 mice via glutathione peroxidase related ferroptosis.
Gao Y; Li J; Wu Q; Wang S; Yang S; Li X; Chen N; Li L; Zhang L
Int Immunopharmacol; 2021 Oct; 99():108002. PubMed ID: 34333354
[TBL] [Abstract][Full Text] [Related]
6. LINC00472 Regulates Ferroptosis of Neurons in Alzheimer's Disease via FOXO1.
Lin P; Wang J; Li Y; Li G; Wang Y
Dement Geriatr Cogn Disord; 2024; 53(3):107-118. PubMed ID: 38574473
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis: a potential therapeutic target for Alzheimer's disease.
Yang L; Nao J
Rev Neurosci; 2023 Jul; 34(5):573-598. PubMed ID: 36514247
[TBL] [Abstract][Full Text] [Related]
8. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease.
Ono K; Tsuji M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023927
[TBL] [Abstract][Full Text] [Related]
9. Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation.
Li L; Li WJ; Zheng XR; Liu QL; Du Q; Lai YJ; Liu SQ
Mol Med; 2022 Jan; 28(1):11. PubMed ID: 35093024
[TBL] [Abstract][Full Text] [Related]
10. Programmed Death of Microglia in Alzheimer's Disease: Autophagy, Ferroptosis, and Pyroptosis.
Qiu Z; Zhang H; Xia M; Gu J; Guo K; Wang H; Miao C
J Prev Alzheimers Dis; 2023; 10(1):95-103. PubMed ID: 36641613
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review.
Zhao D; Yang K; Guo H; Zeng J; Wang S; Xu H; Ge A; Zeng L; Chen S; Ge J
Biomed Pharmacother; 2023 Aug; 164():114312. PubMed ID: 37210894
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of FXN overexpression on ferroptosis in L-Glu-induced SH-SY5Y cells.
Wang M; Xuan T; Li H; An J; Hao T; Cheng J
Acta Histochem; 2024 Jan; 126(1):152135. PubMed ID: 38266318
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
[TBL] [Abstract][Full Text] [Related]
15. Liquid-liquid phase separation in Alzheimer's disease.
Fu Q; Zhang B; Chen X; Chu L
J Mol Med (Berl); 2024 Feb; 102(2):167-181. PubMed ID: 38167731
[TBL] [Abstract][Full Text] [Related]
16. The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review.
Wang X; Li H; Sheng Y; He B; Liu Z; Li W; Yu S; Wang J; Zhang Y; Chen J; Qin L; Meng X
Biomed Pharmacother; 2024 Feb; 171():116071. PubMed ID: 38183741
[TBL] [Abstract][Full Text] [Related]
17. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
[TBL] [Abstract][Full Text] [Related]
18. Iron Dysregulation in Alzheimer's Disease: LA-ICP-MS Bioimaging of the Distribution of Iron and Ferroportin in the CA1 Region of the Human Hippocampus.
Junceda S; Cruz-Alonso M; Fernandez B; Pereiro R; Martínez-Pinilla E; Navarro A
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540715
[TBL] [Abstract][Full Text] [Related]
19. The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer's Disease: from the Perspective of Ferroptosis.
Wu L; Xian X; Tan Z; Dong F; Xu G; Zhang M; Zhang F
Mol Neurobiol; 2023 May; 60(5):2832-2850. PubMed ID: 36735178
[TBL] [Abstract][Full Text] [Related]
20. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
Bhatia V; Sharma S
J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
